Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fraser

Showing results (511-520 of 598) with videos related to

Pageof 60
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Ductal carcinoma in situ: state of the science and roadmap to advance the fieldHenry M Kuerer, Constance T Albarracin, Wei T Yang, et al.
Annals of Surgical Oncology|December 24, 2011
Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancerManfred Kaufmann, Gunter von Minckwitz, Elefhterios P Mamounas, et al.
Histopathology|March 5, 2024
A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR)Veerle Bossuyt, Elena Provenzano, W Fraser Symmans, et al.
Annals of Surgery|January 7, 2011
Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planningMin Yi, Thomas A Buchholz, Funda Meric-Bernstam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 25, 2015
Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working groupElena Provenzano, Veerle Bossuyt, Giuseppe Viale, et al.
The Oncologist|July 16, 2013
Neoadjuvant doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early stage breast cancer and evaluation of βIII-tubulin expression as a predictive markerCristina Saura, Ling-Ming Tseng, Stephen Chan, et al.
Archives of Pathology & Laboratory Medicine|August 17, 2022
Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant ChemotherapySunati Sahoo, Gregor Krings, Yunn-Yi Chen, et al.
Investigational New Drugs|September 28, 2020
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancerClinton Yam, Gaiane M Rauch, Tanbin Rahman, et al.
Cancer Research|February 1, 1997
Use of a "replication-restricted" herpes virus to treat experimental human malignant mesotheliomaJ C Kucharczuk, B Randazzo, M Y Chang, et al.
Journal of Neuro-Oncology|December 22, 2016
Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysisKirtesh R Patel, Stuart H Burri, Danielle Boselli, et al.
Pageof 60

Showing results (511-520 of 598) with videos related to

Sort By:
Pageof 60
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Ductal carcinoma in situ: state of the science and roadmap to advance the fieldHenry M Kuerer, Constance T Albarracin, Wei T Yang, et al.
Annals of Surgical Oncology|December 24, 2011
Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancerManfred Kaufmann, Gunter von Minckwitz, Elefhterios P Mamounas, et al.
Histopathology|March 5, 2024
A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR)Veerle Bossuyt, Elena Provenzano, W Fraser Symmans, et al.
Annals of Surgery|January 7, 2011
Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planningMin Yi, Thomas A Buchholz, Funda Meric-Bernstam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 25, 2015
Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working groupElena Provenzano, Veerle Bossuyt, Giuseppe Viale, et al.
The Oncologist|July 16, 2013
Neoadjuvant doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early stage breast cancer and evaluation of βIII-tubulin expression as a predictive markerCristina Saura, Ling-Ming Tseng, Stephen Chan, et al.
Archives of Pathology & Laboratory Medicine|August 17, 2022
Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant ChemotherapySunati Sahoo, Gregor Krings, Yunn-Yi Chen, et al.
Investigational New Drugs|September 28, 2020
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancerClinton Yam, Gaiane M Rauch, Tanbin Rahman, et al.
Cancer Research|February 1, 1997
Use of a "replication-restricted" herpes virus to treat experimental human malignant mesotheliomaJ C Kucharczuk, B Randazzo, M Y Chang, et al.
Journal of Neuro-Oncology|December 22, 2016
Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysisKirtesh R Patel, Stuart H Burri, Danielle Boselli, et al.
Pageof 60